James Noble, MD, MS, Associate Professor of Neurology in the Taub Institute and the Sergievsky Center at CUMC discusses his diverse body of work and the motivation behind his passion projects.
Lawrence S. Honig, MD, PhD, Professor of Neurology at CUMC, comments on the suggestion that some people may have developed Alzheimer's disease after receiving growth hormones
Caghan Kizil, PhD, MSc, Associate Professor of Neurological Sciences in Neurology and in the Taub Institute, talks about using zebrafish as a model organism in his research.
Many people live years or even decades with dementia, which causes death. Researching the symptoms and causes can dramatically help dementia care and prevention.
As Davangere Devanand, a neurologist at CUIMC, combed through the reams of scientific data on Alzheimer’s, he stumbled across a surprising idea – could an infection be involved in driving the disease?
Of all the possible contributors, intense physical activity was the likely disease-modifying factor, Davangere Devanand, MD, of CUIMC, and co-authors wrote in Alzheimer's & Dementia
"Hispanics and individuals of African ancestry have been significantly underrepresented in research of Alzheimer’s disease, although engaging underserved minorities is critical..." says Dr. Reitz
Research from Scott Small's lab at Columbia University suggests a different approach to tackling the disease, and a new startup company is now trying to turn that approach into treatments.
For more than 20 years, scientists have known that people with hypertension, diabetes, high cholesterol, or obesity have a higher likelihood of developing Alzheimer’s disease.